{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:12:34Z","timestamp":1793725954703,"version":"4.6.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T00:00:00Z","timestamp":1530057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-143210"],"award-info":[{"award-number":["FDN-143210"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-154278"],"award-info":[{"award-number":["FDN-154278"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-84438"],"award-info":[{"award-number":["MOP-84438"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12915-018-0526-3","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T08:58:11Z","timestamp":1527670691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Altering cortical input unmasks synaptic phenotypes in the YAC128 cortico-striatal co-culture model of Huntington disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Mandi E.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caodu","family":"Buren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Dal Cengio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn A.","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,27]]},"reference":[{"key":"526_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"Huntington\u2019s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell. 1993;72:971\u201383.","journal-title":"Cell"},{"key":"526_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","volume":"198","author":"LA Raymond","year":"2011","unstructured":"Raymond LA, Andr\u00e9 VM, Cepeda C, Gladding CM, Milnerwood AJ, Levine MS. Pathophysiology of Huntington\u2019s disease: time-dependent alterations in synaptic and receptor function. Neuroscience. 2011;198:252\u201373.","journal-title":"Neuroscience"},{"key":"526_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","volume":"81","author":"C Cepeda","year":"2007","unstructured":"Cepeda C, Wu N, Andr\u00e9 VM, Cummings DM, Levine MS. The corticostriatal pathway in Huntington\u2019s disease. Prog Neurobiol. 2007;81:253\u201371.","journal-title":"Prog Neurobiol"},{"key":"526_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pneurobio.2017.03.008","volume":"153","author":"S Tyebji","year":"2017","unstructured":"Tyebji S, Hannan AJ. Synaptopathic mechanisms of neurodegeneration and dementia: Insights from Huntington\u2019s disease. Prog Neurobiol. 2017;153:18\u201345.","journal-title":"Prog Neurobiol"},{"key":"526_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fncir.2013.00019","volume":"7","author":"AM Estrada-S\u00e1nchez","year":"2013","unstructured":"Estrada-S\u00e1nchez AM, Rebec GV. Role of cerebral cortex in the neuropathology of Huntington\u2019s disease. Front Neural Circuits. 2013;7:19. \n                    https:\/\/doi.org\/10.3389\/fncir.2013.00019\n                    \n                  .","journal-title":"Front Neural Circuits"},{"key":"526_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1098\/rstb.1971.0102","volume":"262","author":"JM Kemp","year":"1971","unstructured":"Kemp JM, Powell TP. The structure of the caudate nucleus of the cat: light and electron microscopy. Philos Trans R Soc Lond Ser B Biol Sci. 1971;262:383\u2013401.","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"526_CR7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/0306-4522(89)90128-0","volume":"29","author":"AJ McGeorge","year":"1989","unstructured":"McGeorge AJ, Faull RLM. The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience. 1989;29:503\u201337.","journal-title":"Neuroscience"},{"key":"526_CR8","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1523\/JNEUROSCI.11-12-03877.1991","volume":"11","author":"RJ Ferrante","year":"1991","unstructured":"Ferrante RJ, Kowall NW, Richardson EP. Proliferative and degenerative changes in striatal spiny neurons in Huntington\u2019s disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry. J Neurosci. 1991;11:3877\u201387.","journal-title":"J Neurosci"},{"key":"526_CR9","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","volume":"86","author":"GJ Klapstein","year":"2001","unstructured":"Klapstein GJ, Fisher RS, Zanjani H, Cepeda C, Jokel ES, Chesselet MF, et al. Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington\u2019s disease transgenic mice. J Neurophysiol. 2001;86:2667\u201377.","journal-title":"J Neurophysiol"},{"key":"526_CR10","doi-asserted-by":"publisher","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","volume":"21","author":"GA Laforet","year":"2001","unstructured":"Laforet GA, Sapp E, Chase K, McIntyre C, Boyce FM, Campbell M, et al. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington\u2019s disease. J Neurosci. 2001;21:9112\u201323.","journal-title":"J Neurosci"},{"key":"526_CR11","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/nm.3246","volume":"19","author":"S Marco","year":"2013","unstructured":"Marco S, Giralt A, Petrovic MM, Pouladi MA, Mart\u00ednez-Turrillas R, Mart\u00ednez-Hern\u00e1ndez J, et al. Suppressing aberrant GluN3A expression rescues NMDA receptor dysfunction, synapse loss and motor and cognitive decline in Huntington\u2019s disease models. Nat Med. 2013;19:1030\u20138.","journal-title":"Nat Med"},{"key":"526_CR12","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1111\/j.0953-816X.2004.03374.x","volume":"19","author":"TL Spires","year":"2004","unstructured":"Spires TL, Grote HE, Garry S, Cordery PM, Van Dellen A, Blakemore C, et al. Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6\/1 Huntington\u2019s disease transgenic mice. Eur J Neurosci. 2004;19:2799\u2013807.","journal-title":"Eur J Neurosci"},{"key":"526_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1523\/JNEUROSCI.1038-15.2016","volume":"36","author":"J Wu","year":"2016","unstructured":"Wu J, Ryskamp DA, Liang X, Egorova P, Zakharova O, Hung G, et al. Enhanced store-operated calcium entry leads to striatal synaptic loss in a Huntington\u2019s disease mouse model. J Neurosci. 2016;36:125\u201341.","journal-title":"J Neurosci"},{"key":"526_CR14","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","volume":"23","author":"C Cepeda","year":"2003","unstructured":"Cepeda C, Hurst RS, Calvert CR, Hern\u00e1ndez-Echeagaray E, Nguyen OK, Jocoy E, et al. Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington\u2019s disease. J Neurosci. 2003;23:961\u20139.","journal-title":"J Neurosci"},{"key":"526_CR15","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1523\/JNEUROSCI.5687-08.2009","volume":"29","author":"PR Joshi","year":"2009","unstructured":"Joshi PR, Wu N-P, Andr\u00e9 VM, Cummings DM, Cepeda C, Joyce JA, et al. Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease. J Neurosci. 2009;29:2414\u201327.","journal-title":"J Neurosci"},{"issue":"Pt 3","key":"526_CR16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1113\/jphysiol.2007.142448","volume":"585","author":"AJ Milnerwood","year":"2007","unstructured":"Milnerwood AJ, Raymond LA. Corticostriatal synaptic function in mouse models of Huntington\u2019s disease: early effects of huntingtin repeat length and protein load. J Physiol. 2007;585(Pt 3):817\u201331.","journal-title":"J Physiol"},{"key":"526_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","volume":"65","author":"AJ Milnerwood","year":"2010","unstructured":"Milnerwood AJ, Gladding CM, Pouladi MA, Kaufman AM, Hines RM, Boyd JD, et al. Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington\u2019s disease mice. Neuron. 2010;65:178\u201390.","journal-title":"Neuron"},{"key":"526_CR18","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1152\/jn.00933.2015","volume":"116","author":"C Buren","year":"2016","unstructured":"Buren C, Tu G, Parsons MP, Sepers MD, Raymond LA. Influence of cortical synaptic input on striatal neuronal dendritic arborization and sensitivity to excitotoxicity in corticostriatal coculture. J Neurophysiol. 2016;116:380\u201390.","journal-title":"J Neurophysiol"},{"key":"526_CR19","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1523\/JNEUROSCI.4129-11.2012","volume":"32","author":"AM Kaufman","year":"2012","unstructured":"Kaufman AM, Milnerwood AJ, Sepers MD, Coquinco A, She K, Wang L, et al. Opposing roles of synaptic and extrasynaptic NMDA receptor signaling in cocultured striatal and cortical neurons. J Neurosci. 2012;32:3992\u20134003.","journal-title":"J Neurosci"},{"key":"526_CR20","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1046\/j.1460-9568.2003.02696.x","volume":"17","author":"M Segal","year":"2003","unstructured":"Segal M, Greenberger V, Korkotian E. Formation of dendritic spines in cultured striatal neurons depends on excitatory afferent activity. Eur J Neurosci. 2003;17:2573\u201385.","journal-title":"Eur J Neurosci"},{"key":"526_CR21","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1093\/hmg\/dds037","volume":"21","author":"MA Pouladi","year":"2012","unstructured":"Pouladi MA, Stanek LM, Xie Y, Franciosi S, Southwell AL, Deng Y, et al. Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice. Hum Mol Genet. 2012;21:2219\u201332.","journal-title":"Hum Mol Genet"},{"key":"526_CR22","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, et al. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet. 2003;12:1555\u201367.","journal-title":"Hum Mol Genet"},{"key":"526_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.nbd.2015.12.009","volume":"87","author":"C Buren","year":"2016","unstructured":"Buren C, Parsons MP, Smith-Dijak A, Raymond LA. Impaired development of cortico-striatal synaptic connectivity in a cell culture model of Huntington\u2019s disease. Neurobiol Dis. 2016;87:80\u201390.","journal-title":"Neurobiol Dis"},{"key":"526_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.nbd.2012.05.013","volume":"48","author":"AJ Milnerwood","year":"2012","unstructured":"Milnerwood AJ, Kaufman AM, Sepers MD, Gladding CM, Zhang L, Wang L, et al. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington\u2019s disease mice. Neurobiol Dis. 2012;48:40\u201351.","journal-title":"Neurobiol Dis"},{"key":"526_CR25","doi-asserted-by":"publisher","DOI":"10.1042\/AN20100007","volume":"2","author":"DM Cummings","year":"2010","unstructured":"Cummings DM, Cepeda C, Levine MS. Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington\u2019s disease. ASN Neuro. 2010;2:e00036.","journal-title":"ASN Neuro"},{"key":"526_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.nbd.2016.10.006","volume":"97 Pt A","author":"D Ryskamp","year":"2017","unstructured":"Ryskamp D, Wu J, Geva M, Kusko R, Grossman I, Hayden M, et al. The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease. Neurobiol Dis. 2017;97 Pt A:46\u201359.","journal-title":"Neurobiol Dis"},{"key":"526_CR27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.expneurol.2005.07.021","volume":"196","author":"JM Van Raamsdonk","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Rogers DA, Lu G, Barakauskas VE, Barr AM, et al. Ethyl-EPA treatment improves motor dysfunction, but not neurodegeneration in the YAC128 mouse model of Huntington disease. Exp Neurol. 2005;196:266\u201372.","journal-title":"Exp Neurol"},{"key":"526_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1471-4159.2005.03357.x","volume":"95","author":"JM Van Raamsdonk","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Bailey CDC, Rogers DA, Johnson GVW, Hayden MR, et al. Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease. J Neurochem. 2005;95:210\u201320.","journal-title":"J Neurochem"},{"key":"526_CR29","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/hmg\/ddi147","volume":"14","author":"JM Van Raamsdonk","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Rogers DA, Bissada N, Vogl AW, Hayden MR, et al. Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease. Hum Mol Genet. 2005;14:1379\u201392.","journal-title":"Hum Mol Genet"},{"key":"526_CR30","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1097\/00001756-200011270-00032","volume":"11","author":"A van Dellen","year":"2000","unstructured":"van Dellen A, Welch J, Dixon RM, Cordery P, York D, Styles P, et al. N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington\u2019s disease mice. Neuroreport. 2000;11:3751\u20137.","journal-title":"Neuroreport"},{"key":"526_CR31","doi-asserted-by":"publisher","first-page":"6809","DOI":"10.1073\/pnas.120166397","volume":"97","author":"JA Bibb","year":"2000","unstructured":"Bibb JA, Yan Z, Svenningsson P, Snyder GL, Pieribone VA, Horiuchi A, et al. Severe deficiencies in dopamine signaling in presymptomatic Huntington\u2019s disease mice. Proc Natl Acad Sci U S A. 2000;97:6809\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"526_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.nbd.2015.11.020","volume":"86","author":"K Kolodziejczyk","year":"2016","unstructured":"Kolodziejczyk K, Raymond LA. Differential changes in thalamic and cortical excitatory synapses onto striatal spiny projection neurons in a Huntington disease mouse model. Neurobiol Dis. 2016;86:62\u201374.","journal-title":"Neurobiol Dis"},{"key":"526_CR33","first-page":"846","volume":"15","author":"J Kassubek","year":"2005","unstructured":"Kassubek J, Juengling FD, Ecker D, Landwehrmeyer GB. Thalamic atrophy in Huntington\u2019s disease co-varies with cognitive performance: a morphometric MRI analysis. Cereb Cortex N Y N 1991. 2005;15:846\u201353.","journal-title":"Cereb Cortex N Y N 1991"},{"key":"526_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fnana.2014.00030","volume":"8","author":"C Cheng","year":"2014","unstructured":"Cheng C, Trzcinski O, Doering LC. Fluorescent labeling of dendritic spines in cell cultures with the carbocyanine dye \u201cDiI\u201d. Front Neuroanat. 2014;8:30. \n                    https:\/\/doi.org\/10.3389\/fnana.2014.00030\n                    \n                  .","journal-title":"Front Neuroanat"},{"key":"526_CR35","doi-asserted-by":"publisher","first-page":"735","DOI":"10.2217\/fnl.10.41","volume":"5","author":"BR Miller","year":"2010","unstructured":"Miller BR, Bezprozvanny I. Corticostriatal circuit dysfunction in Huntington\u2019s disease: intersection of glutamate, dopamine and calcium. Future Neurol. 2010;5:735\u201356.","journal-title":"Future Neurol"},{"key":"526_CR36","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nm.3514","volume":"20","author":"N Wang","year":"2014","unstructured":"Wang N, Gray M, Lu X-H, Cantle JP, Holley SM, Greiner E, et al. Neuronal targets of mutant huntingtin genetic reduction to ameliorate Huntington\u2019s disease pathogenesis in mice. Nat Med. 2014;20:536\u201341.","journal-title":"Nat Med"},{"key":"526_CR37","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.1523\/JNEUROSCI.2812-14.2015","volume":"35","author":"AM Estrada-S\u00e1nchez","year":"2015","unstructured":"Estrada-S\u00e1nchez AM, Burroughs CL, Cavaliere S, Barton SJ, Chen S, Yang XW, et al. Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington\u2019s disease. J Neurosci. 2015;35:4440\u201351.","journal-title":"J Neurosci"},{"key":"526_CR38","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.3155875","volume":"227","author":"GA Graveland","year":"1985","unstructured":"Graveland GA, Williams RS, DiFiglia M. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington\u2019s disease. Science. 1985;227:770\u20133.","journal-title":"Science"},{"key":"526_CR39","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1523\/JNEUROSCI.3539-10.2011","volume":"31","author":"VM Andr\u00e9","year":"2011","unstructured":"Andr\u00e9 VM, Cepeda C, Fisher YE, Huynh M, Bardakjian N, Singh S, et al. Differential electrophysiological changes in striatal output neurons in Huntington\u2019s disease. J Neurosci. 2011;31:1170\u201382.","journal-title":"J Neurosci"},{"key":"526_CR40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996;87:493\u2013506.","journal-title":"Cell"},{"key":"526_CR41","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/JGP.0b013e318196a632","volume":"17","author":"J Nithianantharajah","year":"2009","unstructured":"Nithianantharajah J, Barkus C, Vijiaratnam N, Clement O, Hannan AJ. Modeling brain reserve: experience-dependent neuronal plasticity in healthy and Huntington\u2019s disease transgenic mice. Am J Geriatr Psychiatry. 2009;17:196\u2013209.","journal-title":"Am J Geriatr Psychiatry"},{"key":"526_CR42","doi-asserted-by":"publisher","first-page":"12997","DOI":"10.1523\/JNEUROSCI.5284-12.2013","volume":"33","author":"RP Murmu","year":"2013","unstructured":"Murmu RP, Li W, Holtmaat A, Li J-Y. Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of Huntington\u2019s disease. J Neurosci. 2013;33:12997\u20133009.","journal-title":"J Neurosci"},{"key":"526_CR43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.brainresbull.2012.01.012","volume":"87","author":"RP Lerner","year":"2012","unstructured":"Lerner RP, Trejo Martinez LDCG, Zhu C, Chesselet M-F, Hickey MA. Striatal atrophy and dendritic alterations in a knock-in mouse model of Huntington\u2019s disease. Brain Res Bull. 2012;87:571\u20138.","journal-title":"Brain Res Bull"},{"key":"526_CR44","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.nbd.2015.10.016","volume":"86","author":"AB Rocher","year":"2016","unstructured":"Rocher AB, Gubellini P, Merienne N, Boussicault L, Petit F, Gipchtein P, et al. Synaptic scaling up in medium spiny neurons of aged BACHD mice: a slow-progression model of Huntington\u2019s disease. Neurobiol Dis. 2016;86:131\u20139.","journal-title":"Neurobiol Dis"},{"key":"526_CR45","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0959-4388(02)00322-7","volume":"12","author":"CM Sauvageot","year":"2002","unstructured":"Sauvageot CM, Stiles CD. Molecular mechanisms controlling cortical gliogenesis. Curr Opin Neurobiol. 2002;12:244\u20139.","journal-title":"Curr Opin Neurobiol"},{"key":"526_CR46","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/S0896-6273(00)80662-5","volume":"21","author":"SN Gomperts","year":"1998","unstructured":"Gomperts SN, Rao A, Craig AM, Malenka RC, Nicoll RA. Postsynaptically silent synapses in single neuron cultures. Neuron. 1998;21:1443\u201351.","journal-title":"Neuron"},{"key":"526_CR47","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1523\/JNEUROSCI.18-14-05294.1998","volume":"18","author":"C Boyer","year":"1998","unstructured":"Boyer C, Schikorski T, Stevens CF. Comparison of hippocampal dendritic spines in culture and in brain. J Neurosci. 1998;18:5294\u2013300.","journal-title":"J Neurosci"},{"key":"526_CR48","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbadis.2009.04.001","volume":"1792","author":"RJ Ferrante","year":"2009","unstructured":"Ferrante RJ. Mouse models of Huntington\u2019s disease and methodological considerations for therapeutic trials. Biochim Biophys Acta. 2009;1792:506\u201320.","journal-title":"Biochim Biophys Acta"},{"key":"526_CR49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jneumeth.2015.09.033","volume":"265","author":"Z Bayram-Weston","year":"2016","unstructured":"Bayram-Weston Z, Olsen E, Harrison DJ, Dunnett SB, Brooks SP. Optimising Golgi\u2013Cox staining for use with perfusion-fixed brain tissue validated in the zQ175 mouse model of Huntington\u2019s disease. J Neurosci Methods. 2016;265:81\u20138.","journal-title":"J Neurosci Methods"}],"container-title":["BMC Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-018-0526-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12915-018-0526-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-018-0526-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T10:44:26Z","timestamp":1569062666000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiol.biomedcentral.com\/articles\/10.1186\/s12915-018-0526-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,27]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["526"],"URL":"https:\/\/doi.org\/10.1186\/s12915-018-0526-3","relation":{},"ISSN":["1741-7007"],"issn-type":[{"value":"1741-7007","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,27]]},"assertion":[{"value":"12 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were performed according to protocols approved by the University of British Columbia Animal Care Committee (Protocol number A16-0130).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"MRH was an employee of Teva Pharmaceuticals, Inc. during this study. Teva did not play a role in the design, collection, analysis, or interpretation of data in this study. All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"58"}}